



The  proteasome  is  a  major  nonly-




as  the  cell  cycle,  transcription,  cell 
signaling, cell death, and the immune 
response (Goldberg, 2003). The cat-
alytic  core  of  this  large multisubunit 








tral  catalytic  chamber,  whereas  two 
outer α rings provide the gated entry 










tom  surface  of  the  20S  “barrel”  to 
trigger  opening  of  the  gate  to  allow 
entry of unfolded substrates.
The  REG/11S  particle  consists  of 
REG  subunits  that  are  also  arranged 
in a ring-shaped heptameric complex 





gen  presentation.  In  contrast,  REGγ
(also  called  Ki  antigen  or  PSME3) 
resides  primarily  in  the  nucleus  in  a 
homoheptameric  form,  and  its  func-
tion  has  remained  largely  elusive.  In 
this  issue of Cell, Li et al.  (2006) pro-
vide  evidence  that  the  REGγ-20S 
complex  is  capable  of  selectively 
targeting  an  intact  substrate—in  this 
case, the nuclear receptor SRC-3—for 
destruction. During the investigation of 
the  homeostasis  of  steroid-hormone 
receptors  and  coactivators,  Li  et  al. 
(2006) discovered that REGγ interacts 
selectively  with  SRC-3,  a member  of 
the  p160  nuclear  receptor  coactiva-
tor  family  involved  in  transcriptional 
regulation of genes activated  through 
steroid  receptors  (Liao  et  al.,  2002). 
Overexpression  of  REGγ  accelerated 
the  turnover  rate  of  SRC-3,  whereas 
silencing REGγ  expression with  small 
interfering  RNAs  (siRNAs)  resulted  in 









to  hydrolyze  small  peptides  (Rech-
steiner  and  Hill,  2005).  In  a  cell-free 
proteasome  proteolysis  assay,  full-





the  degradation  of  SRC-3.  Further-
more, the closely related SRC-1, which 
is  incapable of  binding  to REGγ, was 
resistant  to  REGγ-mediated  degra-
dation.  These  data  provide  compel-
ling  evidence  for  the  presence  of  an
alternative mechanism of targeting an 





ological  functions  of  the  REG-20S
proteasome. Unlike the 19S complex, 
the  REG  heptamer  does  not  contain
ATPase  subunits  to  catalyze  protein 
unfolding  and  translocation  into  the 
20S particle. SRC-3 is a 160 kDa pro-
tein  that  contains  distinct  structural 
motifs, including a bHLH-PAS domain 
in the N terminus and a histone acet-
yltransferase  (HAT)  domain  in  the  C 
terminus  that  is  specifically  respon-
sible  for  binding  to  REGγ.  Given  that 
ATP  and  “reverse  chaperones”  were 
absent  in  the  cell-free  proteolytic 
assay,  it  is unclear how the  individual 
domain  structures  unfold  to  yield  the 
linear polypeptide chain  for  threading 
into  the  central  proteasome  channel 
for proteolytic cleavage.
An  intriguing  hypothesis  is  that 
SRC-3 degradation is not mediated by 
conventional unfolding and processive 
threading  of  its  free N  or  C  terminus 




20S  complex.  Interestingly,  an  endo-
proteolytic  activity  has been  revealed
for the 20S proteasome, which cleaves 
at  internal  peptide  bonds  of  naturally 
unfolded  or  unstructured  proteins, 
including the cyclin-dependent kinase 
inhibitor p21cip1 and α-synuclein (Liu et 






Destruction of intact cellular proteins is largely orchestrated by ATP-dependent ubiquitination 
and subsequent degradation by the 26S proteasome. The REG-20S proteasome, however, 
only degrades short peptides. In this issue of Cell, Li et al. (2006) challenge this notion by 
revealing that the proteasomal activator REGγ directs degradation of the steroid receptor 
coactivator SRC-3 by the 20S proteasome in an ATP- and ubiquitin-independent manner.
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al., 2003). Furthermore, the Y box pro-
tein-1 and  translation  initiation  factors 
eIF4G and eIF3a were recently shown 
to  undergo  limited  proteolysis  by  the 
20S  proteasome  through  internal 
endoproteolytic  sites  in  the  absence 
of ATP and ubiquitin  (Baugh and Pili-
penko,  2004;  Sorokin  et  al.,  2005). 
The  internal  SRC-3  sequences  are 




147  residues  are  also  unstructured. 
It  is  possible  that  these  disordered 
regions of SRC-3 may serve as cleav-
age sites for the 20S proteasome. The 
highly  structured  bHLH-PAS  and  the 
HAT  domains,  however,  may  be  too 
large  to  enter  the  20S  proteasome 
in  the  absence  of  ATP-  and  reverse-
chaperone-mediated unfolding. Deter-
mining  the  nature  of  the  proteolytic 
products  generated  by  the  REGγ-
20S proteasome would shed  light on 
whether the 160 kDa SRC-3 protein is 
completely  digested  or  only  partially 
cleaved  through  internal  or  terminal 
unstructured sites.
Although  protein  substrates  sub-
jected  to  endoproteolytic  cleavage 
by  the  20S proteasome  in  vitro  often 
contain  either  overall  or  locally  disor-
dered  structural  features,  they  share 




ficity  in  vivo. However,  the REGγ-20S 
proteasome  appears  highly  selective 
for  SRC-3  as  SRC-1,  SRC-2,  and 
estrogen receptor α are not subject to 
REGγ-mediated turnover. Such speci-
ficity  suggests  that  the  REGγ-20S 
proteasome does not  indiscriminately 
degrade  substrates  with  disordered 
elements. Given the ATP-independent 
nature of SRC-3 degradation, a poten-
tial  benefit  of  the  physical  interaction 
between REGγ and SRC-3 is to facili-
tate  entry  of  natively  disordered  sites 
of  SRC-3  into  the  central  proteolytic 
chamber  of  the  associated  20S  pro-
teasome.  Introduction  of  a  substrate 
selection step would  impose a  limita-
tion  on  which  cellular  proteins  have 







20S  proteasome  in  the  endoproteo-
lytic cleavage of unstructured proteins 
(Liu  et  al.,  2003), both  in  vitro  and  in 
vivo  degradation  of  SRC-3  mediated 




and  subjected  to  degradation  by  the 
26S proteasome (Lonard et al., 2000). 
The extent of the relative contributions 
or  interplay  of  ubiquitin-dependent 
and -independent processes on SRC-




of  SRC-3  abundance  is  underscored 
by  the  robust  growth-promoting  role 
of  this  steroid  receptor  coactivator  in 
mammary-gland development and  its 
potent  activity  in  promoting  transfor-
mation  and  breast  tumor  formation 
(Liao  et  al.,  2002).  Abnormal  expres-
sion of SRC-3 has been reported in 50
to  60%  of  breast  cancers.  In  parallel 
with the accumulation of SRC-3 levels 




of  estrogen-dependent  cell  growth. 
Interestingly, a recent serial analysis of 
gene  expression  (SAGE)  study  iden-






by  restricting  the  uncontrolled  accu-
mulation of SRC-3.
Given  the  growth-retardation  phe-
notype of REGγ-deficient mice and the 
defects in cell-cycle progression seen 
in  REGγ-deficient  mouse  embryonic 
fibroblasts  (Murata  et  al.,  1999),  the 
observed  growth  inhibition  by  REGγ
in  estrogen-dependent  cells  is  likely 




REGγ-deficient  fibroblasts  are  prone 
to  apoptosis.  These  observations 
have  lead  to  the  proposal  that  REGγ
may block apoptosis, possibly by pro-
moting degradation of  target proteins 
(Rechsteiner  and  Hill,  2005).  Indeed, 
overexpression  of  REGγ  accelerates 
degradation  of  the  hepatitis  C  virus 
core protein (Moriishi et al., 2003). The 
study  by  Li  et  al.  (2006)  provides  a 
starting point to explore the biochemi-
cal mechanism by which REGγ targets 
degradation  of  intact  protein  sub-
strates. Future studies should address 
the  scope,  biochemical  basis,  and 
biological  functions of  this new mode 
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